BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/17/2026 7:19:02 AM | Browse: 4 | Download: 5
Publication Name World Journal of Stem Cells
Manuscript ID 121077
DOI 10.4252/wjsc.121077
Country Egypt
Category Hematology
Manuscript Type Review
Article Title Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing
Manuscript Source Invited Manuscript
All Author List Heba Adel Abd El Ghaffar, Aya Mohamed Adel Arafat, Eman Hazem AbdelTawab Khattab, Mustafa Ashraf Khattab, Ahmed M Khallaf and Shirihan Mahmoud Anwar Mahgoub
Funding Agency and Grant Number
Corresponding Author Aya Mohamed Adel Arafat, Lecturer, MD, Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Al-Saray Street, Cairo 11956, Egypt. aya.arafat@kasralainy.edu.eg
Key Words Artificial intelligence; Hematopoietic stem cells; Machine learning; Deep learning; Drug discovery; Biological products; Automation; Acute myeloid leukemia; Multiple myeloma
Core Tip Artificial intelligence is redefining the study of hematopoietic stem cells (HSCs) by serving as a computational guide to stemness biology. Machine learning and deep learning delineate HSC fate trajectories, unravel age-dependent HSC self-renewal, and identify enriched leukemic stem cell sub-compartments that sustain treatment-resistant leukemia and relapse in acute myeloid leukemia and multiple myeloma. The same approaches expedite leukemic stem cell-targeted drug discovery, model HSC biomanufacturing for digital twins and predict transplant risk using natural language processing. High-performing artificial intelligence models are therefore quantitative surrogates for stem cell state - and span single-cell biology and decision-making across the HSC continuum.
Citation Abd El Ghaffar HA, Arafat AMA, Khattab EHA, Khattab MA, Khallaf AM, Mahgoub SMA. Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing. World J Stem Cells 2026; In press
PDF 121077-in-press.pdf
Received
2026-03-16 03:42
Peer-Review Started
2026-03-16 03:43
First Decision by Editorial Office Director
2026-04-21 09:15
Return for Revision
2026-04-21 09:15
Revised
2026-05-12 18:34
Publication Fee Transferred
Second Decision by Editor
2026-06-10 02:34
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-17 07:19
Articles in Press
2026-06-17 07:19
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-0210 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com